Relevale, Inc.
4Patents
4Active
4Granted
56Portfolio score
Filing activity: Mar 20, 2019 → Nov 30, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11083712B1 | Low concentration delivery of an ergoline derivative for treatment of a headache | Human Necessities | 7 | Active |
| US11541043B2 | Low concentration delivery of an ergoline derivative for treatment of a headache | Human Necessities | 2 | Active |
| US12329749B2 | Low concentration delivery of an ergoline derivative for treatment of a headache | Human Necessities | 0 | Active |
| US12414941B2 | Low concentration delivery of an ergoline derivative for treatment of a headache | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.